Cullinan Therapeutics CGEM
NASDAQ CGEM
$14.92 +0.03 (+0.20%)
At close: Oct 22, 2026 · 4:00 PM EDT

Cullinan Therapeutics (CGEM) Return on Equity [ROE] (2020 - 2026)

Updated

Cullinan Therapeutics' Return on Equity [ROE] came in at -59.51% for Q2 2026, down 19.90 percentage points from -39.61% a year earlier and down 2.46 percentage points from the prior quarter.

Analysis

Cullinan Therapeutics (CGEM) Return on Equity [ROE] (2020 - 2026) Analysis & Trends

For FY2025, Cullinan Therapeutics' Return on Equity [ROE] was -44.02%, down 11.92 percentage points from FY2024.

  • Return on Equity [ROE] has declined in each of the last three years, with a four-year change of -22.45 percentage points (FY2021 to FY2025).
  • Going back by year, Return on Equity [ROE] was -32.10% in FY2024 (-0.73 pp), -31.37% in FY2023 (-54.11 pp), 22.74% in FY2022 (+44.31 pp) and -21.57% in FY2021.
  • The Q2 2026 figure represents the lowest quarterly Return on Equity [ROE] in data going back to Q4 2020.
  • Year-over-year, Return on Equity [ROE] has declined for six consecutive quarters, with an average year-over-year change of -11.31 percentage points over the last eight quarters.
  • The fastest year-over-year change in Return on Equity [ROE] over five years came in Q4 2022 (a gain of 34.98 percentage points), and the weakest in Q4 2023 (a drop of 53.10 percentage points).
  • Business Quant data shows CGEM's Return on Equity [ROE] at -57.05% (Q1 2026), -51.13% (Q4 2025) and -45.96% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 82.09%
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 19.33%
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 7.21%
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 31.52%
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 21.39%
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 83.75%
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -18.38%
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 4.97%
10 Cullinan Therapeutics 921.83 Mn 587.33 Mn - -59.51%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -59.51%
Mar 31, 2026 -57.05%
Dec 31, 2025 -51.13%
Sep 30, 2025 -45.96%
Jun 30, 2025 -39.61%
Mar 31, 2025 -31.30%
Dec 31, 2024 -27.51%
Sep 30, 2024 -22.66%
Jun 30, 2024 -26.64%
Mar 31, 2024 -30.54%
Dec 31, 2023 -33.62%
Sep 30, 2023 -32.35%
Jun 30, 2023 -28.89%
Mar 31, 2023 12.53%
Dec 31, 2022 19.48%
Sep 30, 2022 17.15%
Jun 30, 2022 21.23%
Mar 31, 2022 -19.36%
Dec 31, 2021 -15.50%
Sep 30, 2021 -13.80%
API Access

Cullinan Therapeutics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CGEM&period=max&api_key=YOUR_API_KEY